• The Korean Journal of Nuclear Medicine
• /
• v.30 no.3
• /
• pp.367-371
• /
• 1996

The $MAG_3$ is a tubular excreting radiopharmaceutical for renal image. We synthesized benzoyl $MAG_3\;(Bz-MAG_3)$ and made a kit for labeling with $^{99m}Tc$. We checked the labeling efficieny of $^{99m}Tc$ labeled $MAG_3$ and biodistribution. Labeling efficieny was checked by TLC-SG (acetonitrile/$H_2O$=2/1). After injecting of 1 mCi of $^{99m}Tc-MAG_3$ to ICR-mice, $T_{max}(min),\;T_{1/2}(min)$ were obtained in the renogram. Sequential images (30sec, 2min, 5min, 10min, 15min, 20min) of $^{99m}Tc-MAG_3$ were compared with those of commercial $^{99m}Tc$-DTPA (Du Pont Merck Pharmaceutical Co.) kit. 1) The $R_f$ value of synthesized $^{99m}Tc-MAG_3$ was 0.78 and labeling efficiency was $97.5{\pm}1.9%$ (n=10). 2) The dynamic images of the $^{99m}Tc-MAG_3$ were better than those of the $^{99m}Tc$-DTPA. 3) The $T_{max}(min.)$ and $T_{1/2}(min.)$ of $^{99m}Tc-MAG_3$ (n=10) were $1.5{\pm}0.5$ (left), $1.4{\pm}0.4$ (right), and $4.3{\pm}1.4$ (left), $4.8{\pm}2.0$ (right), respectively. The $T_{max}(min.)$ and $T_{1/2}(min.)$ of $^{99m}Tc$-DTPA (n=7) were $2.7{\pm}1.6$ (left), $2.7{\pm}1.6$ (right), and $3.8{\pm}1.7$ (left), $4.5{\pm}2.7$ (right), respectively. The quaility of image and labeling efficiency of the synthesized $Bz-MAG_3$ kit were excellent, that it was supposed to be used in routine clinical work.

• Journal of Radiopharmaceuticals and Molecular Probes
• /
• v.5 no.1
• /
• pp.18-25
• /
• 2019

2-Nitroimidazole derivatives have been reported to accumulate in hypoxic tissue. We prepared a novel $^{99m}Tc-MAG_3$-2-nitroimidazole and evaluated the feasibility for hypoxia imaging agent. $Bz-MAG_3$-2-nitroimidazole was synthesized by direct coupling of $Bz-MAG_3$ and 2-nitroimidazole using dicyclohexylcarbodiimide. $Bz-MAG_3$-2-nitroimidazole was labeled with $^{99m}Tc$ in the presence of tartaric acid and $SnCl_2-2H_2O$ at $100^{\circ}C$ for 30 min. And the reaction mixture was purified by $C_{18}$ Sep-pak cartridge. The labeling efficiency and the radiochemical purity were checked by ITLC-SG/acetonitrile. The tumor was grown in balb/c mice for 8~13 days after the subcutaneous injection of tumor cells, CT-26 (murine colon adenocarcinoma cell). Biodistribution study and tumor autoradiography were performed in the xenografted mice after i.v injection of 74 kBq/0.1 mL and 19 MBq/0.1 mL of $^{99m}Tc-MAG_3$-2-nitroimidazole, respectively. In vivo images of $^{99m}Tc-MAG_3$-2-nitroimidazole in tumor bearing mice were obtained 1.5 hr post injection. The labeling efficiency was $45{\pm}20%$ and the radiochemical purity after purification was over 95%. Paper electrophoresis confirmed negative charge of $^{99m}Tc-MAG_3$-2-nitroimidazole. $^{99m}Tc-MAG_3$-2-nitroimidazole was very stable at room temperature and its protein binding was 53%. The $^{99m}Tc-MAG_3$-2-nitroimidazole exhibited high uptake in the liver, stomach and intestine. In biodistribution study using tumor bearing mice, the uptakes (% ID/g) of the tumor were $0.5{\pm}0.1$, $0.4{\pm}0.0$, $0.2{\pm}0.1$ and $0.1{\pm}0.1$ at 5, 15, 30 min and 4 hrs. Tumor/muscle ratio were $1.4{\pm}0.1$, $2.2{\pm}0.83$, $3.0{\pm}0.9$, and 3.7 (n=2) for 5, 15, 30 min and 4 hrs. The uptake in hypoxic area was found higher than in non-hypoxic area of tumor tissue by autoradiography. In vivo images showed the relatively faint uptake to the hypoxic tumor region. $^{99m}Tc-MAG_3$-2-nitroimidazole was successfully synthesized and found feasible for imaging hypoxia.

• Proceedings of the Korean Vacuum Society Conference
• /
• 2015.08a
• /
• pp.255-255
• /
• 2015

국제핵융합실험로(ITER)의 3대 목표 중 하나는 핵융합로 개발을 위한 삼중수소증식블랑켓 개념을 시험하고 검증하는 것이며, 이를 위해 시험증식블랑켓(TBM, Test Blanket Module) 프로그램을 마련, 각국이 참여할 수 있도록 하고 있다. 한국도 2012년 국가핵융합위원회 결정에 따라, EU, 일본, 중국, 인도와 함께 TBM 프로그램에 참여하고 있으며, 2021년 설치를 목표로 헬륨냉각 고체증식재 개념의 HCCR (Helilum Cooled Ceramic Reflector) TBM을 설계, 개발하고 있다. 한국형 TBM은 총 4개의 서브모듈과 하나의 후벽(Back Manifold, BM) 으로 구성되며, 각 서브모듈은 플라즈마와 대면하는 일차벽(First Wall, FW), 증식재와 증배재, 반사재를 담고 있는 증식영역(Breeding Zong, BZ), 냉각재 매니폴드 및 구조물 역할을 하는 측벽(Side Wall, SW) 등의 기능부품으로 구성되어 있다. 냉각재는 8 MPa, $300-500^{\circ}C$의 고온고압헬륨을 사용하고, Li2SiO4 혹은 Li2TiO4 형태의 Li 세라믹 증식재를 사용하며, 중성자 증배를 위해 Be 증배재 및 흑연 반사재를 사용한다 [1-3]. 2015년 2월 개념설계검토(CDR, Conceptual Design Review)를 위해, TBM-shield를 포함한 TBM-set 설계가 완료되었으며, 열수력, 구조, 지진, 전자기, 복합하중에 대한 평가가 진행되었다. 본 논문에서는 이 중 H/He-phase에 시험될 EM-TBM과 D-T phase에 시험될 INT-TBM에 대한 열수력 성능 결과를 소개하였다[5]. 각각의 열부하 조건은 0.17과 $0.3MW/m^2$이며, 중성자 조사는 D-T phase 에서만 고려되었다. 구조재 및 사용된 기능소재별 온도 요건을 정의하고, 성능해석 결과와 비교하였으며, 이를 통해 모든 온도 요건을 만족함을 최종 확인하였다. 이러한 온도 분포는 열응력 평가를 위해 구조해석 입력자료로 활용되었다.